| |
| |
|
| Insider
Information: |
Kulkarni Samarth |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
208,122 |
|
|
Indirect Shares
|
200,000 |
|
|
| Direct
Value |
$11,644,426 |
|
|
|
Indirect Value
|
$11,190,000 |
|
|
| Total
Shares |
408,122 |
|
|
| Total
Value |
$22,834,426 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -67.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
|
2024-04-15 |
208,122 |
2024-04-15 |
200,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-02-20 |
4 |
S |
$79.67 |
$507,498 |
D/D |
(6,370) |
194,257 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-11 |
4 |
S |
$78.26 |
$767,105 |
D/D |
(9,802) |
203,705 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-12 |
4 |
S |
$74.44 |
$341,159 |
D/D |
(4,583) |
208,122 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-19 |
4 |
OE |
$1.81 |
$13,137 |
D/D |
7,258 |
141,305 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-20 |
4 |
OE |
$1.81 |
$5,068 |
D/D |
2,800 |
136,847 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-21 |
4 |
OE |
$1.81 |
$5,430 |
D/D |
3,000 |
137,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-24 |
4 |
OE |
$1.81 |
$6,335 |
D/D |
3,500 |
137,547 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-25 |
4 |
OE |
$1.81 |
$9,258 |
D/D |
5,115 |
139,162 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-26 |
4 |
OE |
$1.81 |
$5,928 |
D/D |
3,275 |
137,322 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-27 |
4 |
OE |
$1.81 |
$3,993 |
D/D |
2,206 |
136,253 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• – – |
2017-12-21 |
4 |
OE |
$1.81 |
$27,150 |
D/D |
15,000 |
148,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-06-01 |
4 |
OE |
$1.81 |
$27,150 |
D/D |
15,000 |
163,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-12-07 |
4 |
OE |
$1.81 |
$38,915 |
D/D |
21,500 |
167,290 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-04-29 |
4 |
OE |
$1.81 |
$36,200 |
D/D |
20,000 |
186,542 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-06-17 |
4 |
OE |
$1.81 |
$36,200 |
D/D |
20,000 |
185,801 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-12-16 |
4 |
OE |
$1.81 |
$14,480 |
D/D |
8,000 |
172,320 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-19 |
4 |
OE |
$1.81 |
$7,796 |
D/D |
4,307 |
175,833 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
OE |
$1.81 |
$19,354 |
D/D |
10,693 |
182,219 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-06-01 |
4 |
OE |
$1.81 |
$31,268 |
D/D |
17,275 |
188,801 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-12-10 |
4 |
OE |
$1.81 |
$36,200 |
D/D |
20,000 |
189,189 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-12-29 |
4 |
OE |
$1.81 |
$24,978 |
D/D |
13,800 |
182,989 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-01-15 |
4 |
OE |
$1.81 |
$36,200 |
D/D |
20,000 |
202,989 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,833 |
194,024 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-06-15 |
4 |
OE |
$12.57 |
$377,100 |
D/D |
30,000 |
217,719 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-08-04 |
4 |
OE |
$12.57 |
$18,855 |
D/D |
1,500 |
189,219 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
